PBIO (Pressure BioSciences) Piotroski F-Score: 0 (As of Jul. 10, 2026)


PBIO Pressure BioSciences Inc PBIO
12 GF Score
Price $0.00
View Full Analysis

What is Pressure BioSciences Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Pressure BioSciences has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Pressure BioSciences's Piotroski F-Score or its related term are showing as below:

Pressure BioSciences  (OTCPK:PBIO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Pressure BioSciences Piotroski F-Score Related Terms


Pressure BioSciences Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Pressure BioSciences's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pressure BioSciences Piotroski F-Score Chart

Pressure BioSciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 2.00 6.00 3.00 3.00

Pressure BioSciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.00 3.00 3.00 3.00
PBIO
12GF Score
Pressure BioSciences Inc PBIO
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun24) TTM:Last Year (Jun23) TTM:
Net Income was -5.63 + -9.904 + -8.074 + -7.116 = $-30.72 Mil.
Cash Flow from Operations was -0.732 + -1.132 + -1.86 + -0.706 = $-4.43 Mil.
Revenue was 0.413 + 0.312 + 0.349 + 0.422 = $1.50 Mil.
Gross Profit was 0.184 + -0.021 + 0.116 + 0.044 = $0.32 Mil.
Average Total Assets from the begining of this year (Jun23)
to the end of this year (Jun24) was
(1.676 + 1.602 + 1.05 + 6.992 + 6.879) / 5 = $3.6398 Mil.
Total Assets at the begining of this year (Jun23) was $1.68 Mil.
Long-Term Debt & Capital Lease Obligation was $0.52 Mil.
Total Current Assets was $0.87 Mil.
Total Current Liabilities was $43.58 Mil.
Net Income was -4.462 + -4.458 + -6.858 + -6.923 = $-22.70 Mil.

Revenue was 0.144 + 0.607 + 0.741 + 0.512 = $2.00 Mil.
Gross Profit was 0.018 + -0.664 + 0.382 + 0.255 = $-0.01 Mil.
Average Total Assets from the begining of last year (Jun22)
to the end of last year (Jun23) was
(2.887 + 2.84 + 2.01 + 2.214 + 1.676) / 5 = $2.3254 Mil.
Total Assets at the begining of last year (Jun22) was $2.89 Mil.
Long-Term Debt & Capital Lease Obligation was $0.24 Mil.
Total Current Assets was $1.05 Mil.
Total Current Liabilities was $26.54 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Pressure BioSciences's current Net Income (TTM) was -30.72. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Pressure BioSciences's current Cash Flow from Operations (TTM) was -4.43. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun23)
=-30.724/1.676
=-18.33174224

ROA (Last Year)=Net Income/Total Assets (Jun22)
=-22.701/2.887
=-7.86317977

Pressure BioSciences's return on assets of this year was -18.33174224. Pressure BioSciences's return on assets of last year was -7.86317977. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Pressure BioSciences's current Net Income (TTM) was -30.72. Pressure BioSciences's current Cash Flow from Operations (TTM) was -4.43. ==> -4.43 > -30.72 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun23 to Jun24
=0.519/3.6398
=0.14259025

Gearing (Last Year: Jun23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun22 to Jun23
=0.244/2.3254
=0.10492818

Pressure BioSciences's gearing of this year was 0.14259025. Pressure BioSciences's gearing of last year was 0.10492818. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun24)=Total Current Assets/Total Current Liabilities
=0.874/43.575
=0.02005737

Current Ratio (Last Year: Jun23)=Total Current Assets/Total Current Liabilities
=1.049/26.541
=0.03952376

Pressure BioSciences's current ratio of this year was 0.02005737. Pressure BioSciences's current ratio of last year was 0.03952376. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Pressure BioSciences's number of shares in issue this year was 51.412. Pressure BioSciences's number of shares in issue last year was 19.471. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0.323/1.496
=0.21590909

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=-0.009/2.004
=-0.00449102

Pressure BioSciences's gross margin of this year was 0.21590909. Pressure BioSciences's gross margin of last year was -0.00449102. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun23)
=1.496/1.676
=0.89260143

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun22)
=2.004/2.887
=0.69414617

Pressure BioSciences's asset turnover of this year was 0.89260143. Pressure BioSciences's asset turnover of last year was 0.69414617. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Pressure BioSciences has an F-score of 3. It is a bad or low score, which usually implies poor business operation.


Pressure BioSciences Business Description

Address 14 Norfolk Avenue, South Easton, MA, USA, 02375
Pressure BioSciences Inc is engaged in the healthcare division. The firm is a leader in the development & sale of enabling, pressure-based platform solutions for the world-wide life sciences industry. The company has developed and patented a technology platform that can control the sample preparation process. This process, called pressure cycling technology (PCT), uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels. The company is also the distributor of the Constant Systems (CS) cell disruption equipment, parts, and consumables. Its products include Barocyclers, External Pressure Calibration Device Kits, MicroTubes, HUB High-Pressure Generators, and Accessories.
12GF Score

Get the complete analysis for PBIO

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price